<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281420/" ref="ordinalpos=4536&amp;ncbi_uid=5273355&amp;link_uid=PMC3281420" image-link="/pmc/articles/PMC3281420/figure/f4-cancers-03-01639/" class="imagepopup">Figure 4. From: Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. </a></div><br /><div class="p4l_captionBody">ATM kinase activity downregulates c-FLIPL and c-FLIPS at the protein level and connects DNA damage signaling to TRAIL-induced apoptosis signaling pathway. DNA damaging agents induce ATM activation, which promotes c-FLIPL protein degradation and c-FLIPS downregulation through an unknown mechanism (Stagni et al. [122]).</div></div>